DMKJ
LENZ

David M. Knott Jr’s LENZ Therapeutics LENZ Stock Holding History

David M. Knott Jr’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-33,732
Closed -$309K – 94
2026
Q1 		$309K Sell
33,732
-20,000
-37% -$281K 0.18% 53
2025
Q4 		$860K Sell
53,732
-28,268
-34% -$824K 0.4% 37
2025
Q3 		$3.82M Hold
82,000
– – 1.54% 15
2025
Q2 		$2.4M Buy
+82,000
New +$2.23M 1.09% 18

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

David M. Knott Jr's LENZ Position: Q2 2026 in Review

David M. Knott Jr sold out of LENZ Therapeutics (LENZ) in Q2 2026, closing a stake of 33,732 shares — an estimated $309K sold.

David M. Knott Jr first reported a position in LENZ in Q2 2025 and held it in 4 quarters. The position peaked at $3.82M in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • David M. Knott Jr reported no remaining LENZ Therapeutics position as of Q2 2026 after selling out during the quarter.
  • David M. Knott Jr sold 33,732 LENZ Therapeutics shares in Q2 2026, an estimated $309K.
  • David M. Knott Jr first reported a position in LENZ Therapeutics in Q2 2025 and held it in 4 quarters.
  • David M. Knott Jr's LENZ Therapeutics position peaked at $3.82M in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on David M. Knott Jr's 13F filing for Q2 2026, filed 12 Aug 2026.